NEWS & PRESS

LATEST UPDATES

Announcements on Uncharted Impact's partnerships, commercialization milestones, and global market expansion.

PRESS RELEASES

OFFICIAL ANNOUNCEMENTS

PartnershipJuly 2026

Uncharted Impact Partners with Medical Home Pharmacy to Reach U.S. Patients

Uncharted Impact, through its Lipotope and Wavve operations, has partnered with Medical Home Pharmacy to make its nasal-spray formulations available to patients across the United States. The partnership pairs telemedicine-based prescribing with nationwide direct-to-patient fulfillment under FDA 503A and 503B compounding standards, and it includes real-world evidence collection to support future regulatory work. Medical Home Pharmacy is completing a state-by-state prescribing rollout expected to reach all fifty states in 2026, materially expanding the reach of Uncharted Impact’s delivery platform in the U.S. market.

PartnershipJuly 2026

Uncharted Impact Expands International Distribution with NanolabsRX

Uncharted Impact’s consumer health products are reaching international markets through its distribution partner NanolabsRX. In the United Kingdom, more than ten thousand units have already been sold under the Lyposol brand through a live e-commerce channel, with press coverage across outlets including Men’s Health, The Telegraph, and Sky. Building on that early traction, the partners are extending distribution into additional international markets, supported by United States Certificates of Free Sale that clear the products for export. The NanolabsRX relationship is a cornerstone of Uncharted Impact’s strategy to bring proven formulations to consumers worldwide.

MEDIA INQUIRIES

Talk to our communications team

For press inquiries, interview requests, or additional information, please reach out and we'll get back to you promptly.

press@uncharted-impact.com